Anti-inflammatory and antirheumatic products, non-steroids

PheWeb

RX_NSAID

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC M01A

292335

Check pre-conditions, main-only, mode, ICD version None

240197

Check minimum number of events

Min. number of events 3

240197

Include endpoints

RX_BUTYLPYRA

RX_ACETICDERIV

RX_OXICAMS

RX_PROPIONIX

RX_FENAMATES

RX_COXIBS

RX_NSAID_OTHER

240197

RX_NSAID

Extra metadata

First used in FinnGen datafreeze DF4

Similar endpoints

↥

List of similar endpoints to Anti-inflammatory and antirheumatic products, non-steroids based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	232234	138334	93900
Unadjusted prevalence (%)	75.27	79.72	69.54
Mean age at first event (years)	41.50	39.38	44.63

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.01	0.80 [0.73, 0.87]	9.3e-8	15523
15 years	0.01	0.60 [0.56, 0.64]	5.0e-46	7810
5 years	0.00	0.61 [0.57, 0.66]	1.1e-37	1697
1 year	0.00	0.62 [0.54, 0.72]	4.0e-10	310

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_NSAID – Anti-inflammatory and antirheumatic products, non-steroids
GWS hits:

Survival analyses between endpoints

↥

Plot

before Anti-inflammatory and antirheumatic products, non-steroids
after Anti-inflammatory and antirheumatic products, non-steroids

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Anti-inflammatory and antirheumatic products, non-steroids

↥